152 - Big Beasts of Clinical Mycology

Friday, October 18, 2024

1:45 PM – 3:00 PM US PT

Location: Petree D

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

George Thompson, III, MD

Professor
Internal Medicine, Division of Infectious Diseases
University of California Davis Medical Center
Sacramento, CA, United States
Ana Alastruey Izquierdo, PhD (she/her/hers)

Research Scientist
Instituto de Salud Carlos III, National Centre for Microbiology. Mycology Reference Laboratory
Majadahonda, Madrid, Spain

Faculty(s)

Charles Thomas, MD

Associate Professor of Medicine, Pulmonary & Critical Care
Mayo Clinic
Rochester, MN, United States
Neil Ampel, MD (he/him/his)

Professor Emeritus of Medicine and Immunobiology
University of Arizona
Tucson, AZ, United States
Ana Alastruey Izquierdo, PhD (she/her/hers)

Research Scientist
Instituto de Salud Carlos III, National Centre for Microbiology. Mycology Reference Laboratory
Majadahonda, Madrid, Spain

Disclosure(s):

George R. Thompson, MD, III: Astellas: Advisor/Consultant (); Cidara: Advisor/Consultant (), Grant/Research Support (); F2G: Advisor/Consultant (), Grant/Research Support (); Melinta: Advisor/Consultant (), Grant/Research Support (); Mundipharma: Advisor/Consultant (), Grant/Research Support (); Pfizer: Advisor/Consultant ()

Ana Alastruey Izquierdo, PhD: Gilead Science: Honoraria (Terminated, December 31, 2023); Mundipharma: Honoraria (Terminated, December 31, 2023); Pfizer, Inc.: Honoraria (Terminated, February 6, 2024)

Charles Thomas, MD: UpToDate Wolters Kluwer Health: Honoraria (Ongoing)

Neil M. Ampel, MD: No financial relationships to disclose

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe the epidemiology, diagnosis, and treatment of pneumocystis infections;
explain changing epidemiology, and the approach to diagnostic and treatment options for coccidioidomycosis;
identify risk factors, diagnostic clues, and the approach to treatment of mucormycosis.

Presentations:

1:45 PM – 2:10 PM US PT

Pneumocystis: New hosts and new treatments
Speaker: Charles Thomas, MD – Mayo Clinic
2:10 PM – 2:35 PM US PT

Coccidioidomycosis: new thoughts on ecology, epidemiology, diagnosis, and treatment
Speaker: Neil M. Ampel, MD (he/him/his) – University of Arizona
2:35 PM – 3:00 PM US PT

Mucormycosis
Speaker: Ana Alastruey Izquierdo, PhD (she/her/hers) – Instituto de Salud Carlos III, National Centre for Microbiology. Mycology Reference Laboratory